Skin regeneration scaffolds: A multimodal bottom-up approach

Trends in Biotechnology

Volumn 30, Issue 12, 2012, Pages 638-648

  Yildirimer, Lara ^a   Thanh, Nguyen T K ^b,c   Seifalian, Alexander M ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DAVY FARADAY RESEARCH LABORATORY   (United Kingdom)

^d ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Burn wounds; Growth factors; Nanotechnology; Nanotopography; Skin regeneration; Stem cells

Indexed keywords

BOTTOM UP APPROACH; BURN WOUNDS; COMPLEX SCAFFOLDS; CRITICAL EVALUATION; CURRENT TREATMENTS; EXTRACELLULAR MATRICES; FUTURE PROSPECTS; GROWTH FACTOR; INTERCELLULAR COMMUNICATIONS; LOCAL DELIVERY; MICRO AND NANOSTRUCTURES; MULTI-MODAL; NANOTOPOGRAPHIES; SCAFFOLD FABRICATION; SKIN REGENERATION; STATUS QUO;

NANOTECHNOLOGY; STEM CELLS;

SCAFFOLDS (BIOLOGY);

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ADULT STEM CELL; ANGIOGENESIS; BIOENGINEERING; CADAVER; COST; DEGRADATION; DERMIS; EXTRACELLULAR MATRIX; GRAFT REJECTION; HALF LIFE TIME; HUMAN; HYDROLYSIS; INFECTION RISK; MESENCHYMAL STEM CELL; NANOENGINEERING; NANOTECHNOLOGY; PATIENT SAFETY; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; SCAR FORMATION; SKIN; SKIN GRAFT; SKIN REGENERATION; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION; VIRUS TRANSMISSION; WOUND HEALING;

ANIMALS; HUMANS; NANOTECHNOLOGY; REGENERATION; SKIN PHYSIOLOGICAL PHENOMENA; SKIN, ARTIFICIAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84869130139     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2012.08.004     Document Type: Review

References (94)

1. Burke J.F., et al. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann. Surg. 1981, 194:413-428.
2. Jones I., et al. A guide to biological skin substitutes. Br. J. Plast. Surg. 2002, 55:185-193.
3. Egaña J.T., et al. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Tissue Eng. Part A 2009, 15:1191-1200.
4. Shevchenko R.V., et al. A review of tissue-engineered skin bioconstructs available for skin reconstruction. J. R. Soc. Interface 2010, 7:229-258.
5. Bianchi F., et al. Microfabrication of fractal polymeric structures for capillary morphogenesis: applications in therapeutic angiogenesis and in the engineering of vascularized tissue. J. Biomed. Mater. Res. Part B: Appl. Biomater. 2007, 81:462-468.
6. Choi J.S., et al. In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 2008, 29:587-596.
7. Kim K.L., et al. Enhanced dermal wound neovascularization by targeted delivery of endothelial progenitor cells using an RGD-g-PLLA scaffold. Biomaterials 2009, 30:3742-3748.
8. Chevallay B., Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med. Biol. Eng. Comput. 2000, 38:211-218.
9. Kim B.S., Mooney D.J. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. 1998, 16:224-230.
10. Edalat F., et al. Material strategies for creating artificial cell-instructive niches. Curr. Opin. Biotechnol. 2012, 10.1016/j.copbio.2012.05.007.
11. Kannan R.Y., et al. Silsesquioxane nanocomposites as tissue implants. Plast. Reconstr. Surg. 2007, 119:1653-1662.
12. Grabb and Smith's Plastic Surgery 2007, Lippincott Williams & Wilkins. 6th edn. C.H. Thorne (Ed.).
13. Alemdaroĝlu C., et al. Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing. J. Biomed. Mater. Res. Part A 2008, 85:271-283.
14. Throm A.M., et al. Development of a cell-derived matrix: effects of epidermal growth factor in chemically defined culture. J. Biomed. Mater. Res. Part A 2010, 92:533-541.
15. Brown G.L., et al. Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann. Surg. 1988, 208:788-794.
16. Tanaka A., et al. Acceleration of wound healing by gelatin film dressings with epidermal growth factor. J. Vet. Med. Sci. 2005, 67:909-913.
17. Ulubayram K., et al. EGF containing gelatin-based wound dressings. Biomaterials 2001, 22:1345-1356.
18. Hardwicke J., et al. Epidermal growth factor therapy and wound healing-past, present and future perspectives. Surgeon 2008, 6:172-177.
19. Thisse B., Thisse C. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev. Biol. 2005, 287:390-402.
20. Dailey L., et al. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 2005, 16:233-247.
21. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
22. Nissen N.N., et al. Differential angiogenic and proliferative activity of surgical and burn wound fluids. J. Trauma 2003, 54:1205-1211.
23. Kibe Y., et al. Spatial and temporal expression of basic fibroblast growth factor protein during wound healing of rat skin. Br. J. Dermatol. 2000, 143:720-727.
24. Komori M., et al. A single local application of recombinant human basic fibroblast growth factor accelerates initial angiogenesis during wound healing in rabbit ear chamber. Anesth. Analg. 2005, 100:830-834.
25. Kinoshita N., et al. The usefulness of basic fibroblast growth factor for radiation-exposed tissue. Wound Repair Regen. 2012, 20:91-102.
26. Akita S., et al. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing. Wound Repair Regen. 2008, 16:635-641.
27. Akita S., et al. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor. J. Burn Care Res. 2006, 27:333-338.
28. Lázár-Molnár E., et al. Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 2000, 12:547-554.
29. Berking C., et al. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am. J. Pathol. 2001, 158:943-953.
30. Wu H., et al. Keratinocyte growth factor augments pulmonary innate immunity through epithelium-driven, GM-CSF-dependent paracrine activation of alveolar macrophages. J. Biol. Chem. 2011, 286:14932-14940.
31. Yazbeck R., et al. Non-invasive detection of a palifermin-mediated adaptive response following chemotherapy-induced damage to the distal small intestine of rats. Cancer Biol. Ther. 2011, 12:399-406.
32. Spielberger R., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. New Engl. J. Med. 2004, 351:2590-2598.
33. Finch P.W., Rubin J.S. Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair. Adv. Cancer Res. 2004, 91:69-136.
34. Marchese C., et al. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J. Exp. Med. 1995, 182:1369-1376.
35. Brauchle M., et al. Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J. Invest. Dermatol. 1995, 105:579-584.
36. Werner S., et al. Induction of keratinocyte growth factor expression is reduced and delayed during wound healing in the genetically diabetic mouse. J. Invest. Dermatol. 1994, 103:469-473.
37. Staiano-Coico L., et al. Human keratinocyte growth factor effects in a porcine model of epidermal wound healing. J. Exp. Med. 1993, 178:865-878.
38. Peng C., et al. Lack of keratinocyte growth factor retards angiogenesis in cutaneous wounds. J. Int. Med. Res. 2011, 39:416-423.
39. Chung L.W., et al. Human prostate cancer model: roles of growth factors and extracellular matrices. J. Cell. Biochem. Suppl. 1992, 16H:99-105.
40. Zang X.-P., et al. Enhanced motility of KGF-transfected breast cancer cells. Anticancer Res. 2006, 26:961-966.
41. Zang X.-P., et al. Influence of KGF on the progression of pancreatic cancer. Anticancer Res. 2009, 29:3417-3420.
42. Drinkwater S.L., et al. Effect of venous ulcer exudates on angiogenesis in vitro. Br. J. Surg. 2002, 89:709-713.
43. Wise L.M., et al. The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration. Cell. Microbiol. 2012, 14:1376-1390.
44. Brem H., et al. Mechanism of sustained release of vascular endothelial growth factor in accelerating experimental diabetic healing. J. Invest. Dermatol. 2009, 129:2275-2287.
45. Ferrara N., Henzel W.J. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 1989, 161:851-858.
46. Unemori E.N., et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol. 1992, 153:557-562.
47. Koolwijk P., et al. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J. Cell Biol. 1996, 132:1177-1188.
48. Bates D.O., Curry F.E. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am. J. Physiol. 1996, 271:H2520-H2528.
49. Connolly D.T., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Investig. 1989, 84:1470-1478.
50. Kwon M.J., et al. Effective healing of diabetic skin wounds by using nonviral gene therapy based on minicircle vascular endothelial growth factor DNA and a cationic dendrimer. J. Gene Med. 2012, 14:272-278.
51. Galeano M., et al. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit. Care Med. 2003, 31:1017-1025.
52. Yeung C.-K., et al. Primary CD30+ve cutaneous T-cell lymphoma associated with chronic burn injury in a patient with longstanding psoriasis. Am. J. Dermatopathol. 2004, 26:394-396.
53. Morihara K., et al. Primary cutaneous anaplastic large cell lymphoma associated with vascular endothelial growth factor arising from a burn scar. J. Am. Acad. Dermatol. 2007, 57:S103-S105.
54. Dasu M.R.K., et al. IGF-I gene transfer effects on inflammatory elements present after thermal trauma. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 285:R741-R746.
55. Spies M., et al. Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound. Gene Ther. 2001, 8:1409-1415.
56. Gartner M.H., et al. Insulin-like growth factors I and II expression in the healing wound. J. Surg. Res. 1992, 52:389-394.
57. Liu J.P., et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
58. Semenova E., et al. Overexpression of mIGF-1 in keratinocytes improves wound healing and accelerates hair follicle formation and cycling in mice. Am. J. Pathol. 2008, 173:1295-1310.
59. Daian T., et al. Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts. J. Invest. Dermatol. 2003, 120:956-962.
60. Mueller R.V., et al. The effect of insulinlike growth factor I on wound healing variables and macrophages in rats. Arch. Surg. 1994, 129:262-265.
61. Hirsch T., et al. Insulin-like growth factor-1 gene therapy and cell transplantation in diabetic wounds. J. Gene Med. 2008, 10:1247-1252.
62. DiGiovanni J., et al. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res. 2000, 60:1561-1570.
63. Bol D.K., et al. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene 1997, 14:1725-1734.
64. Clark R.A. Regulation of fibroplasia in cutaneous wound repair. Am. J. Med. Sci. 1993, 306:42-48.
65. Uhl E., et al. Influence of platelet-derived growth factor on microcirculation during normal and impaired wound healing. Wound Repair Regen. 2003, 11:361-367.
66. Greenhalgh D.G., et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 1990, 136:1235-1246.
67. Rajkumar V.S., et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am. J. Pathol. 2006, 169:2254-2265.
68. Goudie E.B., et al. Multimodal therapy as an algorithm to limb salvage in diabetic patients with large heel ulcers. Int. Wound J. 2012, 9:132-138.
69. Faler B.J., et al. Transforming growth factor-beta and wound healing. Perspect. Vasc. Surg. Endovasc. Ther. 2006, 18:55-62.
70. Murphy K.E., et al. A two-compartment mechanochemical model of the roles of transforming growth factor β and tissue tension in dermal wound healing. J. Theor. Biol. 2011, 272:145-159.
71. Schmid P., et al. Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am. J. Pathol. 1998, 152:485-493.
72. Tomasek J.J., et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
73. Shah M., et al. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 1995, 108:985-1002.
74. Lin R.Y., et al. Exogenous transforming growth factor-beta amplifies its own expression and induces scar formation in a model of human fetal skin repair. Ann. Surg. 1995, 222:146-154.
75. Tremblay P.-L., et al. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am. J. Transplant. 2005, 5:1002-1010.
76. Yang Y., et al. Electrospun fibers with plasmid bFGF polyplex loadings promote skin wound healing in diabetic rats. Mol. Pharm. 2012, 9:48-58.
77. Barrientos S., et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008, 16:585-601.
78. Wong V.W., et al. Engineered pullulan-collagen composite dermal hydrogels improve early cutaneous wound healing. Tissue Eng. Part A 2011, 17:631-644.
79. Yildirimer L., et al. Toxicology and clinical potential of nanoparticles. Nano Today 2011, 6:585-607.
80. Schäfer M., Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol. 2008, 9:628-638.
81. Griffiths M., et al. Survival of Apligraf in acute human wounds. Tissue Eng. 2004, 10:1180-1195.
82. Ehrenreich M., Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng. 2006, 12:2407-2424.
83. Eaglstein W.H., Falanga V. Tissue engineering for skin: an update. J. Am. Acad. Dermatol. 1998, 39:1007-1010.
84. Kim P.J., et al. A closer look at bioengineered alternative tissues. Podiatry Today 2006, 19:38-55.
85. Wood F.M., et al. The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature. Burns 2006, 32:395-401.
86. Panzavolta S., et al. Porous composite scaffolds based on gelatin and partially hydrolyzed alpha-tricalcium phosphate. Acta Biomater. 2009, 5:636-643.
87. Rustad K.C., et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials 2012, 33:80-90.
88. Wu Y., et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007, 25:2648-2659.
89. Hocking A.M., Gibran N.S. Mesenchymal stem cells: paracrine signaling and differentiation during cutaneous wound repair. Exp. Cell Res. 2010, 316:2213-2219.
90. Wagner J., et al. Optimizing mesenchymal stem cell-based therapeutics. Curr. Opin. Biotechnol. 2009, 20:531-536.
91. Liu S., et al. Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair. Tissue Eng. Part A 2011, 17:725-739.
92. Kim W.-S., et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J. Dermatol. Sci. 2007, 48:15-24.
93. Zhou Y., et al. Expansion and delivery of adipose-derived mesenchymal stem cells on three microcarriers for soft tissue regeneration. Tissue Eng. Part A 2011, 17:2981-2997.
94. Dazzi F., Horwood N.J. Potential of mesenchymal stem cell therapy. Curr. Opin. Oncol. 2007, 19:650-655.